165 related articles for article (PubMed ID: 36326315)
1. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
[TBL] [Abstract][Full Text] [Related]
2. The risk of cancer in patients with primary Sjögren syndrome; A single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazisiz V
Turk J Med Sci; 2021 Nov; ():. PubMed ID: 34800937
[TBL] [Abstract][Full Text] [Related]
3. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.
Brom M; Moyano S; Gandino IJ; Scolnik M; Soriano ER
Rheumatol Int; 2019 Oct; 39(10):1697-1702. PubMed ID: 31471716
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
7. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
9. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome.
Brito-Zerón P; Kostov B; Fraile G; Caravia-Durán D; Maure B; Rascón FJ; Zamora M; Casanovas A; Lopez-Dupla M; Ripoll M; Pinilla B; Fonseca E; Akasbi M; de la Red G; Duarte-Millán MA; Fanlo P; Guisado-Vasco P; Pérez-Alvarez R; Chamorro AJ; Morcillo C; Jiménez-Heredia I; Sánchez-Berná I; López-Guillermo A; Ramos-Casals M;
J Hematol Oncol; 2017 Apr; 10(1):90. PubMed ID: 28416003
[TBL] [Abstract][Full Text] [Related]
10. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database.
Goulabchand R; Malafaye N; Jacot W; Witkowski Durand Viel P; Morel J; Lukas C; Rozier P; Lamure S; Noel D; Molinari N; Mura T; Guilpain P
Autoimmun Rev; 2021 Dec; 20(12):102987. PubMed ID: 34718160
[TBL] [Abstract][Full Text] [Related]
12. Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Deng J; Liu M; Xiao R; Wang J; Liao X; Ye Z; Sun Z
Front Immunol; 2022; 13():904682. PubMed ID: 35844507
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Relationship Between Primary Sjögren Syndrome and Non-Hodgkin Lymphoma: A Nationwide Taiwanese Population-based Study.
Wang LH; Wang WM; Lin CY; Lin SH; Shieh CC
J Rheumatol; 2020 Sep; 47(9):1374-1378. PubMed ID: 31941803
[TBL] [Abstract][Full Text] [Related]
14. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract][Full Text] [Related]
15. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
16. Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan.
Yu KH; Kuo CF; Huang LH; Huang WK; See LC
Medicine (Baltimore); 2016 May; 95(18):e3540. PubMed ID: 27149461
[TBL] [Abstract][Full Text] [Related]
17. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort.
Zhang W; Feng S; Yan S; Zhao Y; Li M; Sun J; Zhang FC; Cui Q; Dong Y
Rheumatology (Oxford); 2010 Mar; 49(3):571-7. PubMed ID: 20040528
[TBL] [Abstract][Full Text] [Related]
18. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
19. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
20. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]